Antibiotic Choice for Pediatric Patients with History of C. difficile

Understanding the Clinical Context and Antibiotic Selection

The American Academy of Pediatrics recommends questioning the necessity of antibiotic therapy rigorously, as many pediatric infections do not require antibiotics, in patients with a history of C. difficile infection 1
The Infectious Diseases Society of America suggests using watchful waiting when clinically appropriate for conditions like acute otitis media in children >6 months with non-severe symptoms, to minimize antibiotic use 1

The American Academy of Pediatrics recommends using narrow-spectrum penicillins (penicillin VK, amoxicillin without clavulanate) for streptococcal infections in pediatric patients with a history of C. difficile, as they are lower risk options 1
The Infectious Diseases Society of America suggests using first-generation cephalosporins (cephalexin) when beta-lactams are needed, as they are also lower risk options 1
The American Academy of Pediatrics recommends using macrolides (azithromycin) for atypical coverage when required, although they are not risk-free 2

The American Academy of Pediatrics recommends using the shortest effective duration of antibiotics and avoiding extended courses that further disrupt microbiota, as well as avoiding prophylactic antibiotics unless absolutely indicated 1

The Infectious Diseases Society of America recommends oral vancomycin 10 mg/kg/dose four times daily (maximum 125 mg per dose) for 10 days for first recurrence of C. difficile infection, if metronidazole was used initially 3, 2
The Society recommends a vancomycin tapered and pulsed regimen for second or subsequent recurrences: 10 mg/kg/dose (maximum 125 mg) four times daily for 10-14 days, then twice daily for 7 days, then once daily for 7 days, then every 2-3 days for 2-8 weeks 3, 2
The American Gastroenterological Association suggests considering fecal microbiota transplantation for multiple recurrences after third episode or later 4, 5, 3

The Infectious Diseases Society of America recommends not using metronidazole for recurrent C. difficile infection, due to lower cure rates, higher recurrence risk, and neurotoxicity concerns with repeated exposure 4, 5, 3
The American Academy of Pediatrics recommends not using antimotility agents (loperamide) if C. difficile infection is suspected, as this can precipitate toxic megacolon 1